ArticleFrontiers in immunology2022

Based on different immune responses under the glucose metabolizing type of papillary thyroid cancer and the response to anti-PD-1 therapy.

Wenjun Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.